Clothianidin-resistant Anopheles gambiae adult mosquitoes from Yaoundé, Cameroon, display reduced susceptibility to SumiShield® 50WG, a neonicotinoid formulation for indoor residual spraying
- PMID: 38273227
- PMCID: PMC10811947
- DOI: 10.1186/s12879-024-09030-8
Clothianidin-resistant Anopheles gambiae adult mosquitoes from Yaoundé, Cameroon, display reduced susceptibility to SumiShield® 50WG, a neonicotinoid formulation for indoor residual spraying
Abstract
Background: Chronic exposure of mosquito larvae to pesticide residues and cross-resistance mechanisms are major drivers of tolerance to insecticides used for vector control. This presents a concern for the efficacy of clothianidin, an agricultural neonicotinoid prequalified for Indoor Residual Spraying (IRS).
Methods: Using standard bioassays, we tested if reduced susceptibility to clothianidin can affect the efficacy of SumiShield® 50WG, one of four new IRS formulations containing clothianidin. We simultaneously monitored susceptibility to clothianidin and to SumiShield 50WG, testing adults of Anopheles gambiae, An. coluzzii and Culex sp sampled from urban, suburban and agricultural areas of Yaoundé, Cameroon.
Results: We found that in this geographic area, the level of susceptibility to the active ingredient predicted the efficacy of SumiShield 50WG. This formulation was very potent against populations that reached 100% mortality within 72 h of exposure to a discriminating concentration of clothianidin. By contrast, mortality leveled off at 75.4 ± 3.5% within 7 days of exposure to SumiShield 50WG in An. gambiae adults collected from a farm where the spraying of the two neonicotinoids acetamiprid and imidacloprid for crop protection is likely driving resistance to clothianidin.
Conclusions: Despite the relatively small geographic extend of the study, the findings suggest that cross-resistance may impact the efficacy of some new IRS formulations and that alternative compounds could be prioritized in areas where neonicotinoid resistance is emerging.
Keywords: Anopheles; Clothianidin; Malaria; Neonicotinoids; Resistance; SumiShield® 50WG.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Update of
-
Resistance to clothianidin reduces the efficacy of SumiShield® 50WG, a neonicotinoid formulation for indoor residual spraying, against Anopheles gambiae.Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2847231. doi: 10.21203/rs.3.rs-2847231/v1. Res Sq. 2023. Update in: BMC Infect Dis. 2024 Jan 25;24(1):133. doi: 10.1186/s12879-024-09030-8. PMID: 37162950 Free PMC article. Updated. Preprint.
Similar articles
-
Adult mosquitoes of the sibling species Anopheles gambiae and Anopheles coluzzii exhibit contrasting patterns of susceptibility to four neonicotinoid insecticides along an urban-to-rural gradient in Yaoundé, Cameroon.Malar J. 2024 Mar 2;23(1):65. doi: 10.1186/s12936-024-04876-4. Malar J. 2024. PMID: 38431623 Free PMC article.
-
Resistance to clothianidin reduces the efficacy of SumiShield® 50WG, a neonicotinoid formulation for indoor residual spraying, against Anopheles gambiae.Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2847231. doi: 10.21203/rs.3.rs-2847231/v1. Res Sq. 2023. Update in: BMC Infect Dis. 2024 Jan 25;24(1):133. doi: 10.1186/s12879-024-09030-8. PMID: 37162950 Free PMC article. Updated. Preprint.
-
Efficacy of a novel mode of action of an indoor residual spraying product, SumiShield® 50WG against susceptible and resistant populations of Anopheles gambiae (s.l.) in Benin, West Africa.Parasit Vectors. 2018 May 10;11(1):293. doi: 10.1186/s13071-018-2869-6. Parasit Vectors. 2018. PMID: 29747684 Free PMC article.
-
Susceptibility testing of Anopheles malaria vectors with the neonicotinoid insecticide clothianidin; results from 16 African countries, in preparation for indoor residual spraying with new insecticide formulations.Malar J. 2019 Aug 1;18(1):264. doi: 10.1186/s12936-019-2888-6. Malar J. 2019. PMID: 31370898 Free PMC article.
-
Significant variations in tolerance to clothianidin and pirimiphos-methyl in Anopheles gambiae and Anopheles funestus populations during a dramatic malaria resurgence despite sustained indoor residual spraying in Uganda.Parasit Vectors. 2025 Jun 23;18(1):237. doi: 10.1186/s13071-025-06867-z. Parasit Vectors. 2025. PMID: 40551263 Free PMC article.
Cited by
-
Susceptibility of Anopheles gambiae s.l. to the neonicotinoid insecticide clothianidin in eighteen sites located along the south-north transect of Benin.Trop Med Health. 2025 Feb 12;53(1):21. doi: 10.1186/s41182-025-00694-9. Trop Med Health. 2025. PMID: 39940041 Free PMC article.
-
Temporal evolution of insecticide resistance and bionomics in Anopheles funestus, a key malaria vector in Uganda.Sci Rep. 2024 Dec 30;14(1):32027. doi: 10.1038/s41598-024-83689-6. Sci Rep. 2024. PMID: 39738472 Free PMC article.
-
Assessing Temperature-Dependent Deltamethrin Toxicity in Various kdr Genotypes of Aedes aegypti Mosquitoes.Insects. 2025 Mar 1;16(3):254. doi: 10.3390/insects16030254. Insects. 2025. PMID: 40266744 Free PMC article.
-
Adult mosquitoes of the sibling species Anopheles gambiae and Anopheles coluzzii exhibit contrasting patterns of susceptibility to four neonicotinoid insecticides along an urban-to-rural gradient in Yaoundé, Cameroon.Malar J. 2024 Mar 2;23(1):65. doi: 10.1186/s12936-024-04876-4. Malar J. 2024. PMID: 38431623 Free PMC article.
-
Anopheles gambiae larvae's ability to grow and emerge in water containing lethal concentrations of clothianidin, acetamiprid, or imidacloprid is consistent with cross-resistance to neonicotinoids.Parasit Vectors. 2024 Mar 1;17(1):98. doi: 10.1186/s13071-024-06188-7. Parasit Vectors. 2024. PMID: 38429846 Free PMC article.
References
-
- World Health Organization . Guidelines for malaria vector control. Geneva: Switzerland; 2019. - PubMed
-
- World Health Organization. List of WHO Prequalified Vector Control Products. Geneva; 2023. Available from: https://extranet.who.int/pqweb/vector-control-products/prequalified-prod....
-
- World Health Organization. World malaria report 2022. Geneva; 2022.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical